TickerFacts.

Company research / ZBH

Zimmer Biomet Holdings, Inc. (ZBH)

Build a valuation ↗↓ Download CSV

SEC name ZIMMER BIOMET HOLDINGS, INC. · CIK 0001136869 · NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Zimmer Biomet Holdings, Inc. reported revenue of $8.23B. Revenue grew 7.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $8.51B.

Key ratios (year ended 2025-12-31)

13.3%
Operating margin
8.6%
Net margin
5.5%
Return on year-end equity
7.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Headquarters locality: Warsaw · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$8.51B$8.23B$7.68B$7.39B$6.94B$6.83B$6.13B$7.98B$7.93B$7.80B$7.67B
Cost of Revenue$2.56B$2.49B$2.19B$2.08B$2.02B$1.96B$1.82B$2.25B$2.27B$2.13B$2.38B
R&D Expense$442.80M$458.50M$437.40M$458.70M$406.00M$435.80M$322.80M$449.30M$391.70M$369.90M$365.60M
Operating Income$1.21B$1.10B$1.29B$1.28B$696.30M$860.30M$83.10M$1.14B$33.80M$799.30M$821.10M
Depreciation & Amortization$1.11B$1.09B$996.30M$951.70M$926.40M$937.70M$898.40M$1.01B$1.04B$1.06B$1.04B
EBITDA$2.31B$2.19B$2.28B$2.23B$1.62B$1.80B$981.50M$2.14B$1.07B$1.86B$1.86B
Net Income$806.70M$705.10M$903.80M$1.02B$231.40M$401.60M-$138.90M$1.13B-$379.20M$1.81B$305.90M
EPS (Diluted)n/a$3.55$4.43$4.88$1.10$1.91-$0.67$5.47-$1.86$8.90$1.51
Total Assets$22.80B$23.09B$21.37B$21.50B$21.07B$23.46B$24.42B$24.64B$24.13B$26.01B$26.68B
Total Liabilities$10.17B$10.39B$8.89B$9.01B$9.04B$10.79B$12.22B$12.25B$12.85B$14.28B$17.01B
Shareholders' Equity$12.63B$12.71B$12.48B$12.49B$12.03B$12.67B$12.20B$12.39B$11.28B$11.74B$9.67B
Cash & Equivalents$410.00M$591.90M$525.50M$415.80M$375.70M$378.10M$802.10M$617.90M$542.80M$524.40M$634.10M
Operating Cash Flow$1.74B$1.70B$1.50B$1.58Bn/a$1.50B$1.20B$1.59B$1.75B$1.58B$1.63B
Capital Expenditures$220.30M$224.50M$203.80M$291.10M$187.90M$143.60M$111.90M$207.10M$162.70M$156.00M$184.70M
Free Cash Flow$1.52B$1.47B$1.30B$1.29Bn/a$1.36B$1.09B$1.38B$1.58B$1.43B$1.45B
Share Repurchases$750.80M$487.00M$868.00M$692.20M$126.40Mn/an/an/an/an/a$415.50M
Dividends Paid$188.40M$190.30M$196.00M$200.90M$201.20M$200.10M$198.50M$196.70M$195.20M$193.60M$188.40M
Dividends Per Sharen/a$0.96$0.96$0.96$0.96$0.96$0.96$0.96$0.96$0.96$0.96
Weighted Average Diluted Sharesn/a198.70M203.90M209.70M210.30M210.40M207.00M206.70M203.50M203.70M202.40M
EPS (Basic)n/a$3.56$4.45$4.91$1.10$1.93-$0.67$5.52-$1.86$8.98$1.53

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView